China: Chemicals Invista to Invest 1 Billion Dollar plus to Construct Adiponitrile Facility
The mega project involves building a 300,000-tonne plant which is expected to commence production in 2023. The move has been undertaken to meet China’s long-term ADN requirements.
Shanghai/China – Invista has begun work to bring its latest adiponitrile (ADN) technology to China to satisfy the strong, local demand for the nylon 6,6 intermediate chemical. Engineering for a minimum 300,000-tonne plant is underway at an estimated investment in excess of 1 billion dollars. Construction is targeted for 2020 and production would begin in 2023.
Kyle Redinger—vice president of Invista Intermediates, Asia Pacific, and 2017 Shanghai Magnolia Silver Award winner—has accepted a newly created role dedicated to meeting China’s long-term needs for ADN through capital investments, asset development and commercial arrangements.
Invista has been meeting with customers and industry participants to develop a collaborative strategy focused on meeting China’s local needs for ADN, which is used to make nylon polymer, fibers and other specialty materials such as hexamethylene diisocyanate (HDI) for coatings.
Over the past five years, Invista has invested more than 600 million dollars in China to support the nylon market, including a 215,000-tonne hexamethylenediamine (HMD) plant and a 150,000-tonne polymer plant, at the Shanghai Chemical Industry Park. Invista has also created multiple-generation improvements to the technology over the decades, recently setting production records with the deployment of its latest technology in the U.S.